The clinical course of optic spinal Asian type MS in a population of non-Asian patients A longitudinal study

被引:0
|
作者
Alvarenga, RP
Carellos, S
Mattielo, M
Miranda-Santos, CM
Vasconcelos, CCF
Camargo, SM
Alvarenga, M
Puccioni-Sohler, M
Alvarenga, H
机构
[1] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil
[2] Hosp Lagoa, Rio De Janeiro, Brazil
[3] Severino Sombra Univ, Vassouras, Brazil
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S217 / S218
页数:2
相关论文
共 50 条
  • [31] Thrombotic Profile and Oral Anticoagulation in Asian and Non-Asian Patients With Nonvalvular Atrial Fibrillation
    Gue, Ying X.
    Inoue, Nobutaka
    Spinthakis, Nikolaos
    Takei, Asumi
    Takahara, Hiroyuki
    Otsui, Kazunori
    Lip, Gregory Y. H.
    Gorog, Diana A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (22) : 2822 - 2824
  • [32] Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
    Wang, Y.
    Choueiri, T. K.
    Lee, J-L
    Tan, M-H
    Rha, S. Y.
    North, S. A.
    Kollmannsberger, C. K.
    McDermott, D. F.
    Heng, D. Y. C.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1433 - 1437
  • [33] Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients
    Y Wang
    T K Choueiri
    J-L Lee
    M-H Tan
    S Y Rha
    S A North
    C K Kollmannsberger
    D F McDermott
    D Y C Heng
    British Journal of Cancer, 2014, 110 : 1433 - 1437
  • [34] Clinical, pathological and loss of heterozygosity differences in Wilms tumors between Asian and non-Asian children
    Loke, Benjamin N.
    Wong, Meng Kang
    Tawng, Khawn D.
    Kuick, Chick Hong
    Jain, Sudhanshi
    Lian, Derrick
    Wagner, Elizabeth
    Zou, Yuhan
    Ganesan, Visveswari
    Sim, Siam Wee
    Lee, York Tien
    Chin, Francis
    Chan, Mei Yoke
    Tan, Ah Moy
    Teh, Bin Tean
    Soh, Shui Yen
    Chang, Kenneth T. E.
    Loh, Amos H. P.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (06) : 1234 - 1242
  • [35] Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease
    André J. Scheen
    Clinical Pharmacokinetics, 2020, 59 : 981 - 994
  • [36] Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis
    Hamilton, Sarah N.
    Ho, Cheryl
    Laskin, Janessa
    Zhai, Yongliang
    Mak, Paul
    Wu, Jonn
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (06): : 575 - 580
  • [37] Clinical Outcomes for Nasopharyngeal Cancer in Non-Asian Patients: A Single-Center Experience
    Zahu, Renata
    Urian, Daniela
    Manolescu, Vlad
    Ungureanu, Andrei
    Bodale, Carmen
    Iacob, Alexandru
    Vesa, Stefan Cristian
    Tiple, Cristina
    Kacso, Gabriel
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [38] Epidemiology and Clinical Outcomes of Asians With Hepatocellular Carcinoma (HCC) Compared to Non-Asian Patients
    Wantuck, James M.
    Wong, Robert J.
    Ha, Nghiem B.
    Yip, Benjamin
    Ahmed, Aijaz
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2013, 144 (05) : S721 - S722
  • [39] Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease
    Scheen, Andre J.
    CLINICAL PHARMACOKINETICS, 2020, 59 (08) : 981 - 994
  • [40] Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis
    Zhang, Lingxiao
    Gan, Liangying
    Li, Kexin
    Xie, Panpan
    Tan, Yan
    Wei, Gang
    Yuan, Xiaojuan
    Pratt, Raymond
    Zhou, Yongchun
    Hui, Ai-Min
    Fang, Yi
    Zuo, Li
    Zheng, Qingshan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (09) : 1421 - 1434